Table 1

Demographic and clinical data of Tourette patients (n=21)
Subject Age Sex OCD ADHD YGTSS global YGTSS impairment Current daily medication Lifetime daily medication
1 42 F No No 46 30 None Tiapride up to 600mg
2 18 M Yes No 33 10 Sulpiride 100mg Sulpiride 100mg
3 36 M No No 48 20 None None
4 40 M No No 49 30 Tiapride 100mg Tiapride 300mg
5 19 M N0 No 21 10 None None
6 19 M No No 43 20 None Pimozide 2mg
7 24 M No No 37 10 None None
8 37 M Yes No 57 30 Pimozide 4mg Citalopram 20mg Pimozide 6mg Citalopram 20mg
9 21 M No Yes 56 30 Tiapride 400mg Methylphenidate 60mg Tiapride 800mg Methylphenidate 60mg
10 38 M No No 37 10 None None
11 25 F No Yes 43 20 Pimozide 2mg Methylphenidate 40mg Pimozide 2mg Methylphenidate 40mg
12 23 M No No 24 10 None None
13 22 F No No 37 20 Trimipramine 50mg Trimipramine 50mg
14 24 M No No 49 20 None None
15 27 M No No 47 20 Trimipramine 100mg Trimipramine 100mg
16 27 M Yes No 55 30 None None
17 28 F No No 47 20 Pimozide 2mg Pimozide 2mg
18 47 M Yes No 69 30 None None
19 48 M No No 37 20 None None
20 48 M No No 53 30 None Tiapride 100mg
21 35 M Yes No 48 20 None Tiapride up to 400mg

(OCD = comorbid obsessive compulsive disorder, ADHD = comorbid attention deficit hyperactivity disorder, YGTSS = Yale Global Tic Severity Scale).

Neuner et al.

Neuner et al. BMC Neurology 2012 12:120   doi:10.1186/1471-2377-12-120

Open Data